FRA:PSH0 - Deutsche Boerse Ag - CA81752F1062 - Common Stock - Currency: EUR
FRA:PSH0 (5/27/2025, 7:00:00 PM)
0.136
0 (-2.86%)
The current stock price of PSH0.DE is 0.136 EUR. In the past month the price increased by 2.26%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
4AB.DE | ABBVIE INC | 18.14 | 288.98B | ||
AMG.DE | AMGEN INC | 13.42 | 131.60B | ||
GIS.DE | GILEAD SCIENCES INC | 14.12 | 119.42B | ||
VX1.DE | VERTEX PHARMACEUTICALS INC | N/A | 100.90B | ||
1REGN.MI | REGENERON PHARMACEUTICALS | 13.85 | 58.22B | ||
ARGX.BR | ARGENX SE | 109.7 | 31.48B | ||
22UA.DE | BIONTECH SE-ADR | N/A | 20.94B | ||
IDP.DE | BIOGEN INC | 8.15 | 16.61B | ||
1BMRN.MI | BIOMARIN PHARMACEUTICAL INC | 34 | 9.98B | ||
0QF.DE | MODERNA INC | N/A | 9.26B | ||
1MRNA.MI | MODERNA INC | N/A | 8.79B | ||
BIO.DE | BIOTEST AG | 65.85 | 1.69B |
Sernova Biotherapeutics Inc. is a clinical-stage biotechnology company, which engages in advancing regenerative medicine in the treatment of chronic diseases. The company is headquartered in London, Ontario and currently employs 17 full-time employees. A bio-hybrid organ is comprised of non-biomaterials, such as the Cell Pouch, integrated with living tissues to restore or enhance the function of a compromised organ. This approach aims to deliver a potentially revolutionary treatment for patients with chronic diseases, initially focusing on type 1 diabetes (T1D) and thyroid disorders. Cell Pouch is a bio-hybrid organ which is surgically implanted beneath the skin of the abdomen.
SERNOVA BIOTHERAPEUTICS INC
700 Collip Circle, Ste 114
London ONTARIO CA
Employees: 17
Phone: 15198585184
The current stock price of PSH0.DE is 0.136 EUR. The price decreased by -2.86% in the last trading session.
The exchange symbol of SERNOVA BIOTHERAPEUTICS INC is PSH0 and it is listed on the Deutsche Boerse Ag exchange.
PSH0.DE stock is listed on the Deutsche Boerse Ag exchange.
8 analysts have analysed PSH0.DE and the average price target is 1.6 EUR. This implies a price increase of 1079.9% is expected in the next year compared to the current price of 0.136. Check the SERNOVA BIOTHERAPEUTICS INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
SERNOVA BIOTHERAPEUTICS INC (PSH0.DE) has a market capitalization of 44.67M EUR. This makes PSH0.DE a Nano Cap stock.
SERNOVA BIOTHERAPEUTICS INC (PSH0.DE) currently has 17 employees.
SERNOVA BIOTHERAPEUTICS INC (PSH0.DE) has a support level at 0.13 and a resistance level at 0.15. Check the full technical report for a detailed analysis of PSH0.DE support and resistance levels.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
PSH0.DE does not pay a dividend.
SERNOVA BIOTHERAPEUTICS INC (PSH0.DE) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.06).
ChartMill assigns a technical rating of 3 / 10 to PSH0.DE.
Over the last trailing twelve months PSH0.DE reported a non-GAAP Earnings per Share(EPS) of -0.06. The EPS increased by 30.77% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -914.25% | ||
ROE | N/A | ||
Debt/Equity | N/A |
ChartMill assigns a Buy % Consensus number of 80% to PSH0.DE. The Buy consensus is the average rating of analysts ratings from 8 analysts.